BACKGROUND: Vitamin D deficiency has been implicated in decreased insulin secretion and increased insulin resistance, hallmarks of type 2 diabetes mellitus. We tested the hypothesis that low plasma 25-hydroxyvitamin D [25(OH)D] is associated with increased risk of type 2 diabetes in the general population.
The pathogenesis of type 2 diabetes mellitus involves the development of a relative deficiency in insulin secretion and insulin resistance (1 ) . Deficient vitamin D status has been associated with decreased insulin secretion and increased insulin resistance in animals and humans (2) (3) (4) (5) (6) (7) (8) (9) . Moreover, substitution with vitamin D in the deficient state has been associated with improvement in insulin secretion and glucose tolerance (5, 7, 9 ) . These studies thus suggest a link between vitamin D deficiency and type 2 diabetes.
Observational and randomized studies on vitamin D concentrations or intake and risk of type 2 diabetes have been contradictory (10 ) . In general, observational studies suggest that higher plasma 25-hydroxyvitamin D [25(OH)D] 4 concentrations and higher vitamin D intake are associated with lower risk of type 2 diabetes. However, randomized studies do not show an effect of vitamin D supplementation on low risk of type 2 diabetes. Several factors have been proposed to explain these seemingly contradictory results, such as residual confounding in observational studies and insufficient doses in randomized studies. It is thus unclear at present whether low plasma 25(OH)D concentrations are associated with increased risk of type 2 diabetes.
We tested the hypothesis that low plasma 25(OH)D is associated with increased risk of type 2 diabetes in the general population. For this purpose, we studied 9841 white individuals from the Copenhagen City Heart Study followed for up to 29 years. We used seasonally unadjusted clinical categories of Ն20 g/L [Ն50 nmol/L] (sufficient), 10 -19.9 g/L [25-49.9 nmol/L] (insufficient), 5-9.9 g/L [12.5-24.9 nmol/L] (deficient), and Ͻ5 g/L [Ͻ12.5 nmol/L] (severely deficient), as well as concentrations adjusted for seasonal variation. Furthermore, the association of low plasma 25(OH)D concentrations with increased risk of type 2 diabetes was summarized in a meta-analysis including present and previous studies.
Materials and Methods

STUDY DESIGN
The Copenhagen City Heart Study is a prospective cohort study of the Danish general population initiated in 1976 -1978 with follow-up examinations in 1981-1983, 1991-1994, and 2001-2003 (11 ) . Individuals 20 -100 years of age were drawn randomly from the national Danish Central Person Register and invited to participate; all inhabitants in Denmark are uniquely identified through their central person registration number that also holds information on date of birth and sex.
The present study included 9841 participants from the 1981-1983 examination (18 089 invited; 70% response rate) who were free of type 2 diabetes at baseline, had a nonfasting plasma glucose Ͻ198 mg/dL [Ͻ11 mmol/L] at baseline (fasting glucose concentrations were not available), and had available plasma samples for 25(OH)D measurement.
A Danish ethics committee approved the study (KF100.2039/91 and KF01-144/01). Participants provided written informed consent.
MEASUREMENTS OF 25(OH)D
Plasma samples collected at baseline in [1981] [1982] [1983] were stored at Ϫ20°C 
POTENTIAL CONFOUNDERS
Variables were ascertained in 1981-1983, 1991-1994, and 2001-2003 (11 ) and used as time-varying variables in multivariable adjusted models. Information on smoking habits was obtained from self-reported questionnaires completed together with an examiner on the day of attendance. Participants also reported their level of income (high, medium, or low) and duration and intensity of leisure-time physical activities (h/week) in self-reported questionnaires reviewed together with an examiner on the day of attendance. Body mass index (BMI) was calculated as measured weight (kilograms) divided by measured height (meters) squared.
ENDPOINT
Incident type 2 diabetes was self-reported diabetes and use of antidiabetic medicine at follow-up examination (1991) (1992) (1993) (1994) (13 ) . We chose to carry out analyses using both clinical categories with absolute values and month-specific quartiles. Although month-specific quartiles may be more suitable for biological hypothesis testing, the clinical categories give information that facilitates comparability between studies, and absolute values are also those used clinically, making absolute values transferable to the everyday activities of clinicians.
To evaluate whether storage time was associated with median concentrations of plasma 25(OH)D, we also measured plasma 25(OH)D in 400 participants without diabetes, cancer, heart disease, or other chronic diseases participating in the 1981-1983, 1991-1994, and 2001-2003 examinations of the Copenhagen City Heart Study.
We estimated cumulative incidences using the competing risk proportional subhazard models by the method of Fine and Gray (14 ) , in which competing risk of death was accounted for. The analyses were adjusted for age and year of birth to account for calendar effects. We used age as time scale. The cumulative incidence functions were plotted by seasonally unadjusted clinical categories and seasonally adjusted percentile categories.
We used Cox proportional hazards regression to estimate hazard ratios with 95% CI for incident type 2 diabetes. We used age as time scale with delayed entry (left truncation). Thus, age differences were automatically adjusted for, and analyses are referred to in text, tables, and figures as age adjusted. Multivariable adjusted Cox regression models included (a) risk factors for type 2 diabetes as age, sex, smoking status (never/ ever), BMI, and duration and intensity of leisure time physical activities, (b) income as a measure of social status, and (c) calendar month of blood draw (the latter only for models with clinical categories) as a confounder for 25(OH)D concentrations. We tested for interactions using likelihood ratio tests with Cox regression models including and excluding multiplicative 2-factor interaction terms, the latter nested in the former model. In interaction analyses and stratified analyses, we used log 2 -transformed values of plasma 25(OH)D, whereby a 1-unit decrease corresponds to a 50% lower concentration of plasma 25(OH)D. The proportional hazards assumption was assessed in Cox regression models graphically by plotting Ϫln[Ϫln-(survival)] vs ln(analysis time); we detected no violations of the proportional hazards assumption. The data were 99.8% complete in relation to the included variables (online Supplemental Table S2 ); the missing data were imputed using multivariable chained imputation (mi impute chained) where age and sex were independent variables and BMI, duration and intensity of leisure time physical activities, and income were dependent variables in the model.
We analyzed the data with the statistical package Stata 12.1, including the meta-analysis described below.
META-ANALYSIS
We identified relevant peer-reviewed studies on the as- or "25-hydroxyvitamin D3" or "vitamin D3") AND ("Diabetes Mellitus" [Mesh] or "diabetes"). Inclusion criteria were prospective design; only type 2 diabetes as an endpoint; a general population sample or subsample, not selected on the basis of presence of disease; and information on effect estimates of the association of 25(OH)D concentrations with risk of type 2 diabetes. In total 1335 studies were identified, 32 articles were retrieved for full-text review, and a further 19 articles were excluded after review due to wrong endpoint, no measurement of plasma 25(OH)D, and/or cross-sectional design (online Supplemental Fig. S1 ). This search strategy identified 13 articles representing 15 studies on the association of 25(OH)D plasma concentrations with risk of type 2 diabetes (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) .
Data from each study were extracted by SA and confirmed by BGN. The extracted data included first author; publication year; cohort size and source; reported follow-up time; design; method of vitamin D measurement; method of 25(OH)D categorization; estimates of the association between 25(OH)D concentrations and outcome; ascertainment of diagnosis; and adjustment for age, sex, overweight or obesity, smoking, and physical activity, as these variables are known risk factors for type 2 diabetes and vitamin D deficiency, and season of blood draw, which is associated with plasma vitamin D concentrations. We converted the risk estimates from individual studies to risk estimates for top vs bottom quartiles to obtain more robust synthesized risk estimates (28 ) . For 3 studies, this conversion was not possible (15, 18, 21 ) , and the corresponding authors were contacted to obtain the risk estimates. Some studies did not report mean or median concentrations of 25(OH)D, and in these studies mean concentrations were estimated from the reported distribution of 25(OH)D (17, 25, 26 ) .
We performed the meta-analysis using fixed and random-effect models (29 ) and calculated randomeffect weights using the DerSirmonian and Laird model. Heterogeneity was assessed by the Q statistic and its extent was quantified by I 2 (the fraction of between study variability due to heterogeneity) (30 ) . Publication bias was evaluated by funnel plots, Begg rank correlation test, and Egger regression test. Table 1 and online Supplemental Table S3 Fig. S3) .
Results
THE COPENHAGEN CITY HEART STUDY
The cumulative incidence of type 2 diabetes increased with decreasing concentrations of baseline plasma 25(OH)D expressed in clinical categories (trend, P ϭ 3ϫ10
Ϫ5
) and expressed in seasonally adjusted quartiles (P ϭ 2ϫ10 Ϫ6 ) (Fig. 1) . Multivariable adjusted hazard ratios for type 2 diabetes increased with decreasing concentrations of 25(OH)D by clinical categories and seasonally adjusted quartiles, and were Fig. S4 ).
The multivariable adjusted hazard ratio for type 2 diabetes for a 50% lower concentration of 25(OH)D was 1.12 (1.03-1.21) (Fig. 3) . A 50% lower concentration of 25(OH)D was associated with a hazard ratio Ͼ1.0 in most strata; however, not all individual risk estimates were significant. Nevertheless, as tests of interaction were nonsignificant for all stratifications, except age, after correction for 7 parallel tests using the Bonferroni correction, this implies that low 25(OH)D concentrations associate with increased risk of type 2 diabetes irrespective of category levels of other vari- 
META-ANALYSIS
A total of 14 studies representing 16 cohorts were included in the meta-analysis, with a total of 72 204 participants and 4877 type 2 diabetes events. The characteristics of the studies are summarized in Table 2 and Cumulative incidences were plotted using Fine and Gray competing risks regression accounting for the competing risk of death. Based on 9841 individuals from the Danish general population, the Copenhagen City Heart Study, followed for up to 29 years after blood sampling for measurement of 25(OH)D. (Fig. 4) . Further analyses restricted to studies of the general population or studies with complete adjustment did not change the estimates appreciably. Analyses stratified according to study design likewise did not alter the associations substantially. There was no evidence of between-study heterogeneity (I 2 ϭ 1.4%, P ϭ 0.44) or publication bias (Begg rank correlation test, P ϭ 1.00, and Egger regression test, P ϭ 0.58) (online Supplemental Fig. S5 ). The Anderson et al. study (15 ) differed from the other studies with regard to population, follow-up (mean 1.3 years), adjustment, and ascertainment of diabetes; thus the meta-analysis was repeated without this study resulting in a odds ratio for type 2 diabetes of 1.39 (1.21-1.58).
Discussion
In the largest general population study to date, we observed an increasing risk of type 2 diabetes with decreasing plasma 25(OH)D concentrations. These findings were confirmed in a meta-analysis of prospective cohort and nested case-control studies published until July 2012.
Biologically, our results make sense, since vitamin D status has been implicated in 2 essential processes linked to type 2 diabetes, i.e., insulin secretion and insulin resistance. Multivariable models were adjusted for sex, age, smoking status (never/ever), BMI, income, and duration and intensity of leisure time physical activities. Furthermore, the model with clinical categories for 25(OH)D was adjusted for month of blood sampling. Based on 9841 individuals from the Danish general population, the Copenhagen City Heart Study, followed for up to 29 years after blood sampling for measurement of 25(OH)D.
knockout or vitamin D deficiency impairs glucoseinduced insulin secretion (5, 6, 8, 9, 33 ) ; and the insulin secretory response improves after vitamin D supplementation in both animals and humans (5, 6, 8, 9, 34 ) . (2) Evidence supporting a role for vitamin D in insulin sensitivity: the vitamin D receptor is present in skeletal muscle cells (35 ) ; vitamin D stimulates insulin receptor expression and insulin-induced glucose transport in vitro (36, 37 ) ; vitamin D directly regulates pathways implicated in the regulation of fatty acid metabolism in skeletal muscle and adipose tissue (38 ) ; and low concentrations of vitamin D are associated with impaired insulin sensitivity, whereas substitution with vitamin D in the deficient state improves insulin sensitivity (2-4, 9, 39 ) . However, several randomized studies have also shown contrasting results with no improvement in insulin secretion or sensitivity after vitamin D supplementation (10 ) .
Our meta-analysis shows that low concentrations of 25(OH)D are robustly associated with increased risk of type 2 diabetes irrespective of population, level of adjustment, or study design. The estimate from the present meta-analysis is comparable to previous metaanalyses with fewer studies and not including the present study (10, 16 ) . Interestingly, there were no signs of statistical heterogeneity or publication bias in our meta-analysis. Further studies should be randomized intervention studies or genetic epidemiological studies designed to establish causality rather than association as in the present study.
A potential limitation is that our cohort consists of whites of Danish descent living in Denmark (latitude 55-58 degrees north) with less sun exposure than closer to the equator; consequently, our findings would be most applicable to individuals with a similar skin color and a similar level of sun exposure. The delay in measurement from 1981-1983 to 2009 -2010 could raise concern of potential decay of plasma 25(OH)D, but this seems unlikely to have distorted our analyses for several reasons: we noticed the expected seasonal Analyses were adjusted for sex, age, smoking status (never/ever), BMI, income, and duration and intensity of leisure time physical activities (except the one stratified for). Age and BMI were categorized by use of the approximate median. Based on 9841 individuals from the Danish general population, the Copenhagen City Heart Study, followed for up to 29 years after blood sampling for measurement of 25(OH)D. NS ϭ not significant (P Ͼ 1.0) after multiplication of P value by 7 according to the Bonferroni correction. (22, 26 ) ; and a low sample quality for the 25(OH)D measurement would tend to weaken rather than inflate an association. Similarly, the diagnoses were obtained from self-report, hospital discharge, and death registries, thus postponing diagnoses made by the general practitioner alone and leading to potential underreporting by participants. However, this potential underreporting would only tend to weaken rather than inflate an association. Our study has several strengths: our population was homogeneous, we had up to 29 years of follow-up with no loss to follow-up, we could account for other major risk factors associated with risk of type 2 diabetes, and we had the highest statistical power to date to examine the associations of low plasma 25(OH)D concentrations with risk of type 2 diabetes. Furthermore, in Northern Europe, UV-B radiation from the sun is adequate for sufficient endogenous vitamin D production in the skin only during the summer months, and food has never been fortified with vitamin D in Denmark. Thus, this cohort from the Danish general population allows determination of the natural history of the association of vitamin D deficiency with risk of type 2 diabetes.
Clinical applications of the present study should be considered cautiously, as this is an observational study. Randomized interventional trials are needed before supplementation with vitamin D can be recommended for prevention of diabetes.
In conclusion, we observed an association between low plasma 25(OH)D and increased risk of type 2 diabetes in the general population. This finding was substantiated in a meta-analysis. The reference category is the highest category of 25(OH)D in each study, and risk estimates are versus the lowest category of 25(OH)D in each study. On the forest plot, black box areas are proportional to the fixed-effect weight of the individual studies. The white diamonds represent the summary estimate, and CIs correspond to the width of the diamonds. Complete adjustment included adjustment for age, sex, season of blood draw, BMI or other obesity measures, smoking, and physical activity. The Knekt study includes both the Finnish Mobile Clinic Health Examination Survey and the Mini-Finland Health Survey. *The Copenhagen City Heart Study, the present study. ND ϭ no data.
25-Hydroxyvitamin D and Type 2 Diabetes
Clinical Chemistry 59:2 (2013) 9
